MEGIN is the global leader for Magnetoencephalography (MEG) technology, a non-invasive, functional brain mapping solution for the diagnostic workup, treatment strategy and intervention of neurological conditions. Through innovation and passionate exploration of the endless possibilities with MEG, specialists from close to one hundred sites from around the world have used our MEG technology to study pathological and eloquent areas of the brain in patients diagnosed with neurological disorders.
MEGIN Spotlight – Helen DeVos Children’s Hospital discussing Magnetoencephalography
The Helen DeVos Children’s Hospital is a 234-bed regional referral center and teaching hospital based in Michigan. It offers advanced pediatric specialty care with more than 300 pediatric physicians who practice in more than 50 pediatric specialties and programs. The hospital is Michigan’s largest neonatal center and is ranked as one of the Best Children’s Hospital by U.S. News & World Report.